New combo attack on rectal cancer: chemo plus targeted surgery shows promise
NCT ID NCT06048146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 180 people with rectal cancer that had spread to lymph nodes in the pelvis. One group received a three-drug chemotherapy regimen (FOLFOXIRI) followed by surgery to remove the affected lymph nodes. The other group got standard chemoradiotherapy before surgery. The goal was to see if the new approach improves how long people live without the cancer coming back. The trial is complete, and results will help determine if this more intensive treatment is worth the extra side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FOLFOXIRI (irinotecan, oxaliplatin, 5-fluorouracil) and lateral lymph node dissection
- What this could lead to
- If successful, this approach could improve survival and reduce cancer recurrence for people with rectal cancer that has spread to nearby lymph nodes.
- What could go wrong
- This is a completed study with 180 participants, but results are not yet widely confirmed. The three-drug chemo regimen has higher side effects, and the surgery adds risks. Further research is needed to see if it truly beats standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF RECTUM AND ANUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could cutting one amino acid make rectal cancer treatment more effective?
- Can a disposable device improve endoscopic tissue closure?
- GPS for surgeons: navigation tech aims to simplify cancer lymph node removal
- New drug velzatinib tested for Hard-to-Treat stomach and intestinal tumors
- Two-Drug combo aims to wipe out rectal cancer before surgery
- New combo therapy aims to stop liver cancer from coming back